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Objectives. The aim of this study was to compare metabolic risk
factors in men with anginal chest pain and a normal or abnormal
coronary angiogram with those in healthy men .
Background. Risk factors for coronary heart disease, including
lipoprotein abnormalities, hypertension and adiposity, may be
metabolically ineerlinked, with insulin resistance and hyperinsu-
linemia being pivotal to these disturbances .
Methods. Glucose and insulin metabolism, lipids and lipo-
proteins, hemostasis, blood pressure and body fat distribution
were measured in 77 nonobese middle-aged men who had anginal
chest pain (39 with an abnormal coronary anglogram and 38 with
no detectable angiographic abnormality) and were compareo, with
those of 40 healthy then of similar age and body mass index .
Results. Patients with chest pain had higher insulin responses
to an intravenous glucose challenge, lower insulin sensitivity,
lower high density lipoprotein (HDL) and sulifraction 2 choles-
Established risk factors for coronary heart disease in middle-
aged men include smoking, hypertension and hypercholes-
terolernia. However, these account for <50% of the actual
incidence of coronary heart disease (1) and the importance of
ether risk factors is being increasingly realized . Abnormali-
ties in insulin and carbohydrate metabolism have been
suggested to increase the risk of coronary heart disease in
both nondiabetic and diabetic subjects . Leaven (2) has
postulated that insulin resistance with associated hyperinsu-
linemia is a pivotal link to several coronary heart disease risk
factors, including hypertension, glucose intolerance, in-
creased very low density lipoprotein (VLDL) and decreased
high density lipoprotein (HDL) . Insulin has also been linked
to disturbances in fibrinolysis, whereas insulin resistance is
related to obesity, another coronary heart disease risk fac-
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terol, lower apolipoprotein Al, higher triglycerides, greater an-
droid fat and higher systolic blood pressure at rest compared with
levels in healthy control subjects (p < 0 .05). Those with an
abnormal coronary angiograrn had lower tissue plasminogen
activator levels, higher plasminogen activator inhibitor I levels
and more android fat than did those with a normal angiogram
(p .--- 0 .05) . Insulin sensitivity correlated positively with 1-WI
(p < 0.05) and sulifraction 2 (p < 0.001) cholesteeo', and nega-
tively with triglycerides (p < 0 .01), android fat proportion (p <
0.01) and systolic blood pressure (p < 0.05), whereas insulin
response showed converse correlations .
Conclusions . These findings provide new evidence of the cen .
tral role of insulin resistance and hyperinsulinemia in the devel-
opment of risk factors associated with coronary heart disease .
(J Ant Coil Cardiol 1994 ;23 :377-83)
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(or, It thus seems likely that many of these risk factors are
interrelated and that it is inappropriate to study any of them
in isolation when trying to establish their importance in
determining coronary heart disease .
We have undertaken a comprehensive study of these
factors in men presenting with apparent angina and either an
abnormal or a normal coronary angiogram and compared the
findings with those in normal healthy men .
Methods
Study patients . We studied 77 men between 31 and 60
years of age who presented with chest pain typical of angina ;
39 men were shown to have an abnormal coronary angio-
gram (>50% lumen narrowing in one or more epicardial
coronary arteries) and 85% of these had undergone angio-
plasty . Of these 39 patients, 10 had previously had positive
findings on an electrocardiographic (ECG) exercise test
(>1 mm ST depression 80 ms after the J point using the
Bruce protocol), 20 had had negative findings and 9 had not
undergone ECG exercise testing. Seventeen of these men
had previously sustained a myocardial infarction, but not
within 6 months of participating in the study . Thirty-eight
men had no detectable abnormality on their angiogram
0735-1097/94/$7 .00
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(<50% lumen narrowing of any epicardial coronary artery) .
Of this latter group, 14 had had positive findings on an ECG
exercise test (Bruce protocol), 13 had had negative findings
and I I had not undergone ECG exercise testing . No patient
was taking a beta-adrenergic blocking agent or any medica-
tion known to affect lipid or carbohydrate metabolism,
coagulation or fibrinolysis . All were nonobese, defined as
within 20% of their ideal body weight (Metropolitan Life
tables). In addition, we studied a group of 40 apparently
healthy symptomless men of similar age and weight who had
no history of chest pain and had normal findings on a rest
ECG. They were attending the Wynn Institute as part of a
health screening program .
Glucose t tests . After an overnight fast, patients
attended the Wynn Institute to undergo metabolic tests,
including an intravenous glucose tolerance test . They were
instructed to consume a carbohydrate-rich diet (>200 g
carbohydrate/day) for 3 days and not to smoke for a mini-
mum of 10 h before the tests . Age, height, weight, body mass
index (weight/height) and active and rest systolic and dia-
stolic blood pressure measurements were recorded . Patients
rested semirecumbent for the tests, and a basal venous blood
sample was taken without use of a tourniquet for coagulation
and fibrinolysis studies . These samples were processed
immediately and stored at -70°C for later assay . Subsequent
blood samples were obtained through an indwelling catheter
in an antecubital vein. Two fasting samples were taken
approximately 10 min apart for baseline glucose, insulin and
C peptide measurements ; then an intravenous glucose load
was administered (0.5 g/kg body weight) into the other arm .
Subsequent blood samples were taken at 3, 5, 7, 10, 15, 20,
30, 45, 60, 90, 120, 150 and 180 min . Blood samples were
immediately placed on ice and centrifuged within 15 min,
and serum and plasma were either assayed immediately or
stored at -20°C for subsequent assay . Details of present and
past smoking habits, alcohol consumption, exercise habits
and family history of coronary heart disease and diabetes
were recorded. Written informed consent was obtained in
each case. The study was approved by the Ethics Committee
of the Wynn Institute for Metabolic Research .
Glucose, insulin and C peptide measurements
. Plasma
glucose was measured within 6 h using a glucose oxidase
technique
. Plasma insulin and C peptide concentrations were
measured on samples stored at -20°C by radioimmunoas-
says (Guildhay Ltd, Surrey, United Kingdom),
The total area under the glucose, insulin and C peptide
concentration profiles was calculated by the trapezoidal rule
and the incremental area under the curie was then derived
(= total area -- 180 x mean fasting concentration) . First (0 to
10 min) and second (10 to 180 min) phase incremental insulin
areas were distinguished.
The rate of glucose decay during the intravenous glucose
tolerance test was expressed as the glucose elimination
constant
. Glucose elimination was further analyzed by using
the minimal model of glucose disappearance of Bergman et
al.
(3), which provides measures of the sensitivity of glucose
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elimination to insulin (inversely related to insulin resistance)
and glucose-dependent glucose elimination . For a modeling
analysis to be acceptable, parameter estimates were required
to have fractional standard deviations of <100% and to be
positive (3). Measures of insulin sensitivity from this analy-
sis agree well with those derived from the glycemic clamp (4)
and have been the subject of detailed evaluation by our
group (5) .
Lipid and lipoprotein measurements . Total cholesterol
and triglycerides were measured by using fully enzymatic
procedures . High density lipoprotein cholesterol was mea-
sured after heparin manganese precipitation of other lipo-
proteins (6) . The cholesterol content of HDL subfraction 3
was measured after further precipitation with dextran sulfate
(7) . The cholesterol content of HDL subfraction 2 was
calculated by subtracting HDL cholesterol subfraction 3
from total HDL cholesterol . The Friedewald formula (8) was
used to calculate low density lipoprotein (LDL) cholesterol .
Apolipoproteins Al and B were measured by immunotur-
bidimetry (9), whereas lipoprotein (a) was measured with a
commercial kit (Biopool, Sweden) .
Coagulation and fibrinolysis measurements . Fibrinogen,
Factors Vila and Vilc, fibrinopeptide A, tissue plasminogen
activator and plasminogen activator inhibitor I were mea-
sured using established methods (10-15) . Fibrinopeptide A
levels >10 U/ml were considered to represent traumatic
activation of the coagulation system, and the results for
fibrinopeptide A and Factor V11c were excluded in such
samples (n = 6) . The screening procedures employed for the
healthy men did not include tests of hemostasis; thus, these
measurements were not available for this group .
Body fat distribution. Body composition measurements
were performed by dual energy X-ray absorptiometry (16)
using a Lunar DPX . Total and regional lean and fat tissue
measurements were obtained . Android (central body) fat
was measured by selecting a region from the superior iliac
crest upward to include all abdominal and thoracic soft
tissue laterally . The height of this region was two thirds of
the distance from the superior iliac crest to the knee joint .
Percent android fat was calculated as the proportion of
android fat expressed as a percent of the total body fat .
Gynoid (lower body segment) fat was measured by placing a
region of the same height from the lower sacral border
downward to include all soft tissue laterally . Percent gynoid
fat was calculated as the proportion of gynoid fat expressed
as a percent of the total body fat . The precision of the lean
tissue measurements was <2%, whereas that for total and
regional fat tissue was <5% (17) .
Statistical analyses. The distribution of each variable was
examined and normalized by logarithmic or square root
transformation as appropriate . Between-group comparisons
were performed by using analysis of variance . When a
significant result was obtained (p { 5% level), intergroup
comparisons were undertaken using the Scheffe method .
Coagulation and fibrinolysis variables were compared using
unpaired two-tailed Student t tests . Alcohol intake data were
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compared using Kruskal-Wallis analysis of variance because
of the lack of an appropriate transformation . The categoric
variables-smoking, exercise and family history data-were
compared with the chi-square test . Single and multiple linear
regression analyses were used to examine interrelations
between selected variables . Pearson correlation coefficients
were determined on transformed data .
Results
Comparison of all groups revealed no significant differ-
ences in smoking or exercise habits or family history of
diabetes mellitus (Table 1) . Among men with positive angio-
graphic findings, there were no significant differences in any
variable between those with and without a previous myocar-
dial infarction ; these subjects were therefore treated as a
homogeneous group . Among men with angina but negative
angiographic findings, there were no significant differences
in any variable among those with positive or negative ECO
exercise test results, and those not given an ECG exercise
test; thus, these subjects were also treated as a homoge-
neous group .
Comparisons between men with angina and healthy men
(Tables 1 to 4). There was no difference in glucose tolerance
between these two groups . Compared with the normal men,
those presenting with angina had higher incremental insulin
areas due to an 84% to 88% higher second phase insulin area
(p < 0.05). They also had a 26% to 28% lower insulin
sensitivity (p < 0.05) .
There were no differences in total cholesterol, low den-
sity lipoprotein or apolipoprotein B concentrations between
men with angina and healthy men . However, serum triglyc-
eride concentrations were 57% to 68% higher in those with
angina (p < 0 .05), whereas concentrations of HDL choles-
terol, and particularly HDL cholesterol subfraction 2, were
17% to 18% and 35% to 38% lower, respectively (p < 0.05)
Apolipoprotein Al levels were also 12% to 15% lower in
those with angina (p < 0 .05). Lipoprotein (a) concentrations
were insignificantly lower in the healthy men .
There were no differences in height, weight, body mass
index or total body fat between the two groups . However,
the proportion of android fat was 7% to 12% higher in those
with angina than in the normal subjects (p < 0 .05) .
Alcohol consumption was higher in the normal subjects,
whereas systolic blood pressure at rest was 9 to 10 mm Hg
higher in those with angina (p < 0.05) .
Comparison between men with angina and normal or
abnormal angiographic findings (Tables 1 to 4) . Men with
angina and abnormal angiographic findings were on average
4.2 years older and were more likely to report a history of
ischemic heart disease in close family members (68 .4%, p <
0.05) than were with men with angina and normal angio-
graphic findings (36 .8%) (42.5% off normal men had a history
of ischemic heart disease in close family members) . Men
with a normal angiogram consumed 60% less alcohol than
did those with an abnormal angiogram .
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There were no significant differences between those with
a normal or abnormal angiograir in any variable of lipid or
carbohydrate metabolism. Lipoprotein (a) concentrations
were 88% higher in those with an abnormal coronary angio-
gram (p = NS). Those with an abnormal angiogram had a 2%
greater proportion of android fat (p < 0 .05), a 2% lesser
proportion of gynoid fat (p < 0 .05), a 29% lower concentra-
tion of tissue plasminogen activator (p < 0.05) and a 28%
greater concentration of plasminogen activator inhibitor 1
(p < 0.05). There were no other differences in variables of
coagulation and fibrinolysis . No differences in any variable
were found between patients with or without a previous
myocardial infarction in the group with an abnormal angio-
gram .
Interrelations between insulin variables and other coronary
heart disease risk factors (Table 5). There were significant
interrelations between insulin sensitivity or incremental in-
sulin areas and various other risk factors . Insulin sensitivity
was positively related to HDL and UDL subfraction 2
cholesterol but negatively related to triglycerides, android
fat and systolic blood pressure. Incremental insulin area was
positively related to triglycerides, total body fat, android fat
and systolic blood pressure but negatively related to HDL
and HDL subfraction 2 cholesterol .
Discussion
Metabolic abnormalities in nonobese men with angina.
Our results clearly demonstrate significant metabolic abnor-
malities in nonobese men presenting clinically with apparent
angina. These include increased insulin resistance with in-
creased second-phase insulin secretion, increased triglycer-
ides and decreased HDL and l-lDL cholesterol subfraction 2 .
They also have a greater proportion of android adiposity and
a slightly higher systolic blood pressure at rest than do
apparently healthy men . It is of particular interest that these
metabolic abnormalities are found in those whose subse-
quent coronary angiograms showed no significant abnormal-
ities. Such patients may have microvascular rather than
macrovascular coronary vessel disease or endothelial dys-
function related to metabolic abnormalities . The major dif-
ference between those with normal or abnormal angio-
graphic findings was that the latter had an even more marked
android fat distribution and adverse changes in fibrinolytic
factors .
Hyperinsulinemia and coronary heart disease . The great
majority of studies (18) comparing healthy control subjects
and patients with coronary heart disease have demonstrated
elevated insulin concentrations in response to glucose in the
diseased groups . However, because these studies have
mainly focused on survivors of myocardial infarction, the
hyperinsulinemia could be a nonspecific response to tissue
injury. Tzagournis et al. (19) reported elevated insulin re-
sponses in patients with angiographic or ECG evidence of
coronary heart disease, and, more recently, glucose-
stimulated hyperinsulinemia was demonstrated in patients
JACC Vol . 23 . No . 2
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TAN 3. Lipid and Lipoprotein Data for the Three Groups"
with microvascular angina (20) . Our findings of insulin
resistance and hyperinsullemia in paiieras with both
post-
live
and negative angiograms in the group with chest pain are
consistent with these observations and support the possibil-
ity of a direct relation between insulin resistance or hyper
insulinemia, or both, and arterial wall disease . It is never-
theless possible that vascular disease that has not yet
progressed to arterial obstruction may be associated with
hemodynamic abnormalities that could secondarily increase
insulin resistance (21). Against this possibility are several
prospective studies (21-24) demonstrating that elevated in-
sulin concentrations are an independent predictor of coro-
nary heart disease, although some of these studies did not
include HDL cholesterol measurements in their analyses .
Lipid and lipoprotein abnormalities . Men with impaired
glucose tolerance (25) have low HDL cholesterol levels, and
a negative relation exists between HDL cholesterol and
fasting insulin levels in both diabetic and nondiabetic sub-
jects (26). In nondiabetic subjects, this relation is indepen-
dent of other variables (27,28) . Insulin secretion profiles
after glucose loading have also been shown to correlate
inversely with HDL cholesterol levels (29,30) . Our results
demonstrate this relation clearly and suggest that this in-
verse relation is stronger with HDL subfraction 2 choles-
terol . Additionally, we confirm the negative relation between
insulin resistance and both HDL cholesterol and HDL
subfraction 2 cholesterol previously demonstrated (31) . An
association between insulin and triglycerides has been indi-
cated by the elevated triglyceride level seen in insulin
Table 4 . Coagulation and Fibrinolysis Data for the Patients With Angina With
or Without a Positive Angiogram*
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Values are hack-transformed where necessary (resulting in asymmetric mean data ± SE)
.
I
< 015 versus normal men . Apo Al and Apo 3 = apolipoprotein
AI and 13 . respectively : HDL. HDL
:, and HDL, = high density lipoprotein and high density lipoprotein subfractions 2 and i, respectively
-. LDL = low density
lipoprotein : Lp(a) -- lipoprotein (a)
.
Numbers in parentheses indicate range .
deficiency that is normalized when insulin is given . How-
ever, in healthy individuals, elevated insulin levels are
usually associated with elevated triglycerides (32) . Our dataa
show that incremental insulin area is positively related to
triglyceride concentrations . This finding suggests that resis-
tance to insulin action, either on lipoprotein lipase activity or
adipose tissue lipolysis, may be important . Indeed, there is
some direct evidence for a positive correlation between
plasma triglycerides and insulin resistance (33-35) and our
findings confirm this .
Body fat distribution and coronary heart disease . Obesity,
and particularly body fat distribution, is another important
risk factor for coronary heart disease (36-39) . Android fat
distribution is related to an adverse lipid and lipoprotein
profile (40,41). hyperinsulinemia (42) and insulin resistance
(42-44). We have found that dual energy X-ray absorption is
a precise and clinically valid method of assessing body fat
distribution (17,45). In our present study, we have shown
that insulin resistance, though not significantly correlated
with total body fat, is related to android fat distribution .
Although incremental insulin area is positively related to
total body fat. this relation is much stronger with android fat
distribution .
Coagulation and fibrinolysis. An alteration in coagulation
and fibrinolytic factors has been postulated to be involved in
the pathogenesis of coronary heart disease . Increased fibrin-
ogen levels have been consistently associated with coronary
heart disease (46-48) . Factor VII may also he important
(47) . We found no difference in these procoagulant factors
*Values are back-transformed where necessary (resulting in asymmetric mean data ± SE)
. tp < 0 .05 versus men with a normal angiogram
. FAH
plasminogen activator inhibitor 1 ; tPA = tissue plasminogen activator
. Numbers in parentheses indicate range .
Fibrinogen
(glliter)
Factor Vila
(g/liter)
Factor Vilc
(g/liter)
Fibrinopeptide A
(U/ml)
tPA
(U/ml)
PAH
(U/ml)
Men with angina and 265 t 6 91 ± 2
118 ± 6 2 .29
LM±MW MA ± ( .3
normal angiogram
(1 .91-2 .76)
Men with angina and 271 ± 8
92 ± 2
120 ± 5 2 .08
1 .53 ± 0 .18t 19.3 ±
1,51
abnormal angiogram
(1 .70-2 .53)
Total
Cholesterol
(MMA)FIRLI')
LDL
Cholesterol
(nmol/filer)
t-IDL
Cholesterol
(mmolfliter(
Him,
Cholesterol
(mmol"'liter)
HDL,
Cholesterol
Immol ,
literl
Triglycerides
(mmoi"kler)
Apo Al
(mg/dl)
Apo B
img;dh
I_Ma)
(mg/dl)
Normal men 5.15 ± 8 .13, 3 .38 -, 0 .13
1
± 0.05
0 .37 t 0 .03 6 .91 :!- 0M3
0 .95 07 .6 3 .4
77 .4 3 .0 5 .3
(0.88-1 .03)
(4 .1-6.8)
Men with angina 520 t IN TAIMM IMT±mw
0"t±aw UNK±W(V ( .49
117 .5 ; +2 .3 77.2±28
6.8
and normal
angiogram
.38-1
.61)
(3 .9-6.1)
Men with angina 5 .33 ± 0
.0
3.46 ± 0R
I 07 t ± 0.04 0 .23t ± 0 .02 0 .84 ± 0 .03 ( .60 121 .01=2
.7 WA
79.0±24
11
and abnormal
angiogram
(1 .49-1 .71)
(7S11 .2)
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Table S
. Correlations Among Insulin Sensitivity, Incremental Insulin Area and Other Coronary Heart Disease Risk Factors for All Three
Groups Combined (Pearson r values)
I
< OX
tp < OAT tp < 0 .001 . BP = blood pressure, other abbreviations as in Table 3 .
among our patients with angina with and without coronary
angiographic abnormalities . Disturbances of plasminogen-
related factors have also been found in coronary heart
disease, and these were greater in our patients with an
abnormal angiogram than in those with a normal angiogram .
A relation between insulin and plasminogen activator inhib-
itor I has been suggested (49.50). We were unable to find
such a relation with either incremental insulin area or insulin
resistance .
Lindtatim of the study . We did not have data on vari-
ables of coagulation and fibrinolysis in our healthy male
control subjects and were thus unable to assess whether the
levels of any procoagulant factors were significantly different
in our patients with angina. Similarly, we were unable to test
whether levels of plasminogen-related factors in our patients
differed from those in normal men .
Another limitation is that the diagnosis of angina in our
men with no detectable angiographic abnormality was not
always confirmed by ECG exercise testing. However, in
each case, the presenting symptoms were sufficiently con-
vincing for the patient to be selected by experienced cardi-
ologists to undergo angiography .
Conclusions . We found that patients with angina, in con-
trast to normal men, have profound metabolic disturbances
in the absence of the confounding influence of obesity . These
included increased insulin concentrations, increased insulin
resistance, increased triglycerides, decreased HDL choles-
terol, increased android adiposity and increased blood pres-
sure. Patients with angina who had an abnormal coronary
angiogram had increased android adiposity, decreased tissue
plasminogen activator and increased plasminogen activator
inhibitor I compared with levels in those with a normal
angiogram . Both insulin resistance and incremental insulin
area were related to these abnormalities in lipids, lipopro-
teins, fat distribution and blood pressure, providing further
evidence for a pivotal role of insulin resistance and hyper-
insulinemia in the development of coronary heart disease .
We are grateful to the staff of the Wynn Institute for Metabolic Research for
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King's College Hospital, London for permission to study their patients
.
References
1 . Kanp .-I W13 . Meaning of a downward trend in cardiovascular mortality
.
JAMA 1982:247 :877-80 .
2 . Reavcn GM . Role of insulin resistance in human disease
. Diabetes
1988-,37 :1595-607 .
3 . Bergman RN
. Ider YZ, Bowden CR
. Cobefli C
. Quantitative estimation of
insulin sensitivity . Am J Physiol 1979 :2361607-77
4. Bergman RN, Prager R, Volund A . OLefsky JM . Equivalence of the
insulin sensitivity index derived by the minimal model method and the
euglycaemic clamp . J Clin Invest 1987 :79:790-800.
5 . Walton C . Godsland 1 . Proudler Al . Felton C, Wynn V . Evaluation of
four mathematical models of glucose and insulin dynamics with analysis
of the effects of age and obesity
. Am J Physiol 1"2 .262 :E755-62 .
6. Warnick GR. Albers JJ . A comprehensive evaluation of the heparin-
manganese precipitation procedure for estimating high density lipoprotein
cholesterol. J Lipid Res 1978-,19 :65-76.
7 . Gidez LL Miller
W.
Burstein M
. Slagle I Elder HA . Separation and
quantitation of subclasses of human plasma high density lipoproteins by a
simple precipitation procedure . J Lipid Res 1982 .23 :1206--23 .
8 . Friedewald WT, Levy RI . Fredrickson DS . Estimation of the concentra-
tion of low-density lipoprotein cholesterol in plasma without the use of the
preparative ultracentrifuge . Clin Chem 1972 :18:499-502 .
9 . Mount JN . Kearney EM . Rosseneu M . Slavin BM . Immunoturbidimetric
assays for serum apolipoproteins At and B using Cobas Bio centrifugal
analyser
. J Clin Pathol 1988,41 :471-4 .
!0 . Clauss A . Gerinaungsphysiologische schnellmethode zur bestimmung des
fibrinogens . Acta Haematol 1957 :17 :237-46.
11 . Brozovic M
. Stirling Y
. Harricks C
. North WRS. Meade TW . Factor VII
in an industrial population . Br J Haematol 1974 :28:381-91 .
12. Nossel HL, Yudelman 1 . Canfield RE
. Measurement of fibrinopeptide A
in human blood . J Clin Invest 1974,54
:43-53.
13. Chmielewska J . Ranby M, Wiman B. Evidence for a rapid inhibitor to
tissue plasminogen activator in plasma . Thromb Res 1983 :31 :427-36 .
14. Amiral J, Adalbert B . Adam M
. Application of enzyme immunoassays to
coagulation testing. Clin Chem 1984 :30 :1512-6 .
15 . Nilsson K . Rosen S . Friberger P
. A new kit for the determination of tissue
plasminogen activator and its inhibitor in blood
. FiNinolysis 1987 :1 :
163-8 .
16. Mazess RB. Barden HS . Bisek JP. Hanson J
. Dual-energy x-ray absorp-
tiometry for total-body and regional bone-mineral and soft-tissue compo-
sition
. Am J Clin Nutr 1990 ;51 :1106-12 .
17
. Ley CJ . Lees B, Stevenson JC . Sex- and menopause-associated changes
in body-fat distribution
. Am J Clin Nutr 1992 :55 :950-4 .
18 . Stout RW
. Insulin and atheroma : 20-yr perspective . Diabetes Care
1990;13
:631-54
.
19. Tzagountis M . Chiles R . Ryan J
. SkIlman TG . Interrelationships of
hyperinsulinism and hypertriglyceridaemia in young patients with coro-
nary heart disease . Circulation 1968-,38 :1156-63 .
20. Dean JD, Jones CJH, Hutchinson SJ, Peters JR
. Henderson AH . Hyper-
insulinaemia and microvascular angina ("syndrome X"). Lancet 1991
;
337
:456-7 .
21 . Baron AD, Laakso M, Brechtel G, Edelman SV
. Mechanism of insulin
resistance in insulin-dependent diabetes mellitus : a major role for reduced
skeletal muscle blood how
. J Clin Endocrinol Metab 1991 ;73 :637-43 .
22 . Welborn TA, Wearne K
. Coronary heart disease incidence and cardio-
vascular mortality in Busselton with reference to glucose and insulin
concentrations
. Diabetes Care 1979 ;2:154-60.
JACC Vol . 23, No . 2
February 1994 :377-83
Triglycerides
HDL
Cholesterol
HDL 2
Cholesterol
Total
Body Fat
Android
Fat
% Android
Fat
Systolic
BP
Insulin sensitivity
-0.27' 0 .22t
0.31* -0 .08 -0 .17 -0.29* -0.19t
Incremental insulin area
0 .401 -0.30t
-0.40*
0 .26*
0 .41*
0.53* 0.22t
JACC Vol 23, No . 2
February 1994 :377-83
23. Eschwege E, Richard JL . Thibult N, et al
. Coronary heart disease
mortality in relation with diabetes, blood glucose and plasma insulin
levels
: the Paris Prospective Study, ten years later, Horm Metab Res
1985 :15 Suppl :41-6 .
24 . Pydr515 K, Savolainen E, Kaukola S
. Haapakoski J . Plasma insulin as
coronary heart disease risk factor
: relationship to other risk factors and
predictive value during 9 1/2 year follow-up of the Helsinki Policeman
Study population . Acta Med Scand 1985 :701 Suppl :38-52 .
25
. Howard BV, Knowler WC, Vasquez B, Kennedy AL, Pettitt DJ, Bennett
PH
. Plasma and lipoprotein cholesterol and triglyceride in the Pima Indian
population . Arteriosclerosis 1984 ;4:462-71 .
26. Laakso M, Barrett-Connor E . Asymptomatic hyperglycaemia is associ-
ated with lipid and lipoprotein changes favouring atherosclerosis
. Arte-
riosclerosis 1989 :9 :665-72 .
27
. Hornick CA, Fellmeth BD . High density lipoprotein cholesterol, insulin,
and obesity in Samoans . Atherosclerosis 1981 ;39:321-8 .
28 . Laakso M . Py&dN K, Voultilainen E, Marnien J . Plasma insulin and
serum lipids and lipoproteins in middle-aged non-insulin dependent dia-
betic and non-diabetic subjects . Am J Epidemiol 1987 :125 :611-21 .
29. Falko JM, Parr JH . Simpson RN, Wynn V . Lipoprotein analyses in
varying degrees of glucose tolerance
. Am J Med 1987
;83 :641-7 .
30
. Wing RR, Bunlser CH, Kuller LH, Matthews KA . Insulin, body mass
index and cardiovascular risk factors in premenopausal women . Arterio-
sclerosis 1989 ;9 :479-84 .
31 . Godsland IF . Crook D, Walton C . Wynn V . Oliver MF
. Influence of
insulin resistance, secretion and clearance with serum cholesterol . tri-
glycerides, lipoprotein cholesterol and blood pressure to healthy males .
Arteriosclerosis Thromb 1992
:12 :1030-5
.
32
. Manolio TA . Savage PJ . Burke GL, et al . Association of fasting insulin
with blood pressure and lipids in young adults : the CARDIA Study .
Arteriosclerosis 10% ;]0 :430-6.
33
. Tobey TA, Greenfield M, Kraemer F, Reaven GM . Relationship between
insulin resistance, insulin secretion, very low density lipoprotein kinetics,
and plasma triglyceridc levels in normotriglyceridaemic man . Metabolism
1981 ;30:165-71 .
34
. Abbott W . Lillioja S, Young A . Relationships between plasma lipoprotein
concentrations and insulin action in an obese hyperinsulinaemic popula-
tion . Diabetes 1987 ;36:897-904 .
35. Laaksn
M,
Sarlund H, Mykkanen L
. Insulin resistance is associated with
lipid and lipoprotein abnormalities in subjects with varying degrees of
glucose intolerance . Arteriosclerosis 1990 :10 :223-31 .
36. Vague J . The degree of masculine differentiation of obesities : a factor
determining predisposition to diabetes, atherosclerosis, gout, and uric
calculus disease . Am J Clin Nutr 1956 :4 :20-34 .
LEY ET AL
.
	
383
METABOLIC ABNORMALITIES IN ANGINA
37
. Ducimctiere P
. Richard J, Cambien F
. The pattern of subcutaneous fat
distribution in middle-aged men and the risk of coronary heart disease
: the
Paris Prospective Study . Im I
Obes 1986:10 :229-40 .
38. Donahue RP, Abbot RD
. Bloom E, Reed DM, Yano K
. Central obesity
and coronary heart disease . Lancet 1987 :1 :821-4 .
39, Hartz A, Grubb B, Wild R, et al
. The association of waist hip ratio and
angiographically determined coronary artery disease . tnt J Obes 199U
,1 :
657-65 .
40
. Despres JP, Allard C, Tremblay A, Talbot J, Bouchard C
. Evidence for a
regional component of body fatness in the association with se!Um lipids in
men and women
. Metabolism 1985 ;34 :967-73 .
41 . Ostlund RE, Staten M
. Kohrt WM, Schultz J, Malley M . The ratio of
waist-to-hip circumference, plasma insulin level, and glucos,
: intolerance
as independent predictors of HDL2 cholesterol level in )Ider adults
.
N Engl J Med 1990,322
:229-34 .
42
. Vague P, Vallo de Castro J . Vague J
. Association between adipose tissue
distribution and non insulin (type 11) diabetes mellitus . In : Vague J,
Bjorntop P . Guy-Grand B
. Rebuffe-Scrive M, Vague P . editors . Metabolic
Complications of Human Obesities . Amsterdam : Excerpta Medica, 1985
:
77-84
.
43 . Lonroth P. Potential role of adipose tissue for the development of insulin
resistarce in obesity
. Acta Med Scand 1988 ;723 Suppl :91-4 .
44
. Walton C, Godsland IF, Proudler AL Felton CV, Wynn V . Effect of body
mass index and fat distribution on insulin sensitivity
. secretion and
clearance in nonobese healthy men
. J Clin Endocrinol Metab 1992 :75 :
170-5 .
41 Bruce & Lees B
. Whitcroft SIJ, McSweeney G, Shaw RW, Stevenson
JC. Changes in body composition with danazol therapy . Fertil Steril
1991 ;56 :574-6 .
46 . Wilhelmsen L, Svarsudd K, Korsan-Bengtsen K
. et al . Fibrinogen as a
risk factor for stroke and myocardial infarction . N Engl J Med 1984 ;311 :
501-5 .
47. Meade TW . Mellows S . Brozovic M, et al . Haemostatic function and
ischaemic heart disease
: principal results of the Northwick Park Heart
Study
. Lancet 1986 ;1 :533-7 .
48 . Kannel WB. Wolf PA, Castelli WP, D'Agostino RB . Fibrinogen and risk
of cardiovascular death . JAMA 1987:258 :1183-6 .
49 . Vague P, Juhan-Vague 1, Aillaud MF, et al . Correlation between blood
fibrinolytic activity, plasminogen activator inhibitor levels, plasma insulin
level and relative body weight in normal and obese subjects. Metabolism
1986 :35 :250-3 .
50. Julian-Vague 1, Alessi MC, Joly P, et al . Plasma plasminogen activator
inhibitor I in angina pectoris : influence of plasma insulin and acute-phase
response . Arteriosclerosis 1989 :9 :362-7 .
